Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: would this have worked, would it work now?

Yes, hindsight is 20/20. Anyone think it would not work if BOD had put all the license fees into a money management account. Instead of hiring a CEO to acquire, hired a money manager. Having dividends from real companies to enable giving an annual dividend to PTSC shareholders. 10 cents a year and more as more licensees are signed.

Share
New Message
Please login to post a reply